How many drug targets are there? (Q28276660)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	How many drug targets are there?	scientific article

Statements

instance of

scholarly article

0 references

review article

1 reference

stated in

Europe PubMed Central

title

How many drug targets are there? (English)

0 references

author

John P. Overington

series ordinal

1

0 references

Andrew L Hopkins

object named as

Andrew L Hopkins

series ordinal

3

0 references

Bissan Al-Lazikani

object named as

Bissan Al-Lazikani

series ordinal

2

0 references

language of work or name

English

0 references

publication date

December 2006

0 references

published in

Nature Reviews Drug Discovery

0 references

volume

5

0 references

issue

12

0 references

page(s)

993-6

0 references

cites work

Genomic sciences and the medicine of tomorrow

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2199

retrieved

31 March 2020

The role of innovation in drug development

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2199

retrieved

31 March 2020

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2199

retrieved

31 March 2020

The druggable genome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2199

retrieved

31 March 2020

DrugBank: a comprehensive resource for in silico drug discovery and exploration

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2199

retrieved

31 March 2020

Drugs, their targets and the nature and number of drug targets

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2199

retrieved

31 March 2020

Progress and problems in the exploration of therapeutic targets

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2199

retrieved

31 March 2020

Therapeutic targets: progress of their exploration and investigation of their characteristics.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2199

retrieved

31 March 2020

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2199

retrieved

31 March 2020

A small molecule-kinase interaction map for clinical kinase inhibitors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2199

retrieved

31 March 2020

A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2199

retrieved

31 March 2020

Kinase inhibition with BAY 43-9006 in renal cell carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2199

retrieved

31 March 2020

Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2199

retrieved

31 March 2020

Global mapping of pharmacological space

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2199

retrieved

31 March 2020

Can we rationally design promiscuous drugs?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2199

retrieved

31 March 2020

The Pfam protein families database

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2199

retrieved

31 March 2020

The structure of the protein universe and genome evolution

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2199

retrieved

31 March 2020

Completeness in structural genomics.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2199

retrieved

31 March 2020

The Protein Data Bank

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2199

retrieved

31 March 2020

The Nobel chronicles. 1988: James Whyte Black, (b 1924), Gertrude Elion (1918-99), and George H Hitchings (1905-98).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2199

retrieved

31 March 2020

Identifiers

DOI

10.1038/NRD2199

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

258081

Dimensions Publication ID

1016838186

0 references

OpenCitations bibliographic resource ID

258081

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

258081

PubMed publication ID

17139284

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

258081

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28276660&oldid=2175201022"